Charles River Laboratories International Inc Sustainability Reports

Charles River Laboratories International, Inc. provides essential preclinical products and drug discovery, early-stage development, and laboratory services. It supports pharmaceutical companies, biotechnology firms, government agencies, and academic institutions worldwide.

Sector: Professional & technical services

Country: United States

Exchange: New York Stock Exchange

LEI: 549300BSQ0R4UZ5KX287

FIGI: BBG001S7Q271

23 reports from 2009 to 2025

• Charles River Laboratories International Inc 2025 Annual Report
• Charles River Laboratories International Inc 2024 Annual Report
• Charles River Laboratories International Inc 2024 TCFD-Aligned Summary Report
• Charles River Laboratories International Inc 2023 Annual Report
• Charles River Laboratories International Inc 2023 NHP Report